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Background: Plant cell suspension cultures can be used for the production of valuable pharmaceutical and
industrial proteins. When the recombinant protein is secreted into the culture medium, restricting expression to
a defined growth phase can improve both the quality and quantity of the recovered product by minimizing
proteolytic activity. Temporal restriction is also useful for recombinant proteins whose constitutive expression
affects cell growth and viability, such as viral interleukin-10 (vIL-10).
Results: We have developed a novel, tetracycline-inducible system suitable for tobacco BY-2 suspension cells
which increases the yields of vIL-10. The new system is based on a binary vector that is easier to handle than
conventional vectors, contains an enhanced inducible promoter and 5′-UTR to improve yields, and incorporates
a constitutively-expressed visible marker gene to allow the rapid and straightforward selection of the most
promising transformed clones. Stable transformation of BY-2 cells with this vector, without extensive optimization
of the induction conditions, led to a 3.5 fold increase in vIL-10 levels compared to constitutive expression in the
same host.
Conclusions: We have developed an effective and straightforward molecular farming platform technology that
improves both the quality and the quantity of recombinant proteins produced in plant cells, particularly those
whose constitutive expression has a negative impact on plant growth and development. Although we tested the
platform using vIL-10 produced in BY-2 cells, it can be applied to other host/product combinations and is also
useful for basic research requiring strictly controlled transgene expression.Background
Molecular farming is the production of valuable pharma-
ceutical or industrial proteins in whole plants and plant-
based systems such as cell suspension cultures [1-6].
Inducible promoters are often used to restrict transgene
expression to particular developmental stages in whole
plants, or to particular growth phases in cultivated cells,
because this can improve product quality and quantity.
In cell suspension cultures, it is beneficial to produce
secreted recombinant proteins during exponential growth
because the beginning of the stationary phase is usually* Correspondence: stefan.schillberg@ime.fraunhofer.de
2Fraunhofer Institute for Molecular Biology and Applied Ecology (IME),
Forckenbeckstrasse 6, 52074, Aachen, Germany
Full list of author information is available at the end of the article
© 2012 Bortesi et al.; licencee BioMed Central
Commons Attribution License (http://creativec
reproduction in any medium, provided the oraccompanied by the release of proteases that degrade
secreted proteins [7,8]. Ideally, bioprocess conditions that
minimize proteolysis should be identified and transgene
expression should be restricted to the most productive
growth phase to prevent extensive protein degradation
and loss of activity [9]. Another important justification
for the temporal restriction of transgene expression is the
tendency for some proteins to inhibit growth and devel-
opment of the host cells when expressed constitutively,
thus reducing yields. For example, if the recombinant
protein is an enzyme, its activity can alter cellular metab-
olism leading to severe pleiotropic effects [10] or it can
limit the amount of recombinant protein that the host
can produce [11]. Recombinant proteins can also physic-
ally interfere with host cellular components leading to
highly detrimental or even lethal phenotypes [12,13].Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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inflammatory cytokine interleukin-10 (vIL-10) in trans-
genic tobacco plants, and found that retention of the
recombinant protein in the endoplasmic reticulum (ER)
resulted in stunted plant growth, with the severity of the
phenotype determined by the level of protein accumula-
tion [14 and Additional file 1: Figure S1]. Subsequent
transient expression experiments have shown that vIL-10
is harmful to the plant not only when it is contained
within the ER, but also in the cytosol or following secre-
tion to the apoplast, both of which led to rapid necrosis
of the infiltrated leaf area (unpublished data). Even plastid
transformation, which is known to protect plants from
the toxic effects of some recombinant proteins, produced
transplastomic plants with a severe mutant phenotype
and low levels of recombinant protein (unpublished data).
We therefore decided to express vIL-10 in the tobacco
cell line Bright Yellow 2 (BY-2) and to develop strategies
based on temporally-restricted inducible expression to
avoid the deleterious effects observed in planta.
Conditional plant expression systems have been devel-
oped using elements from both prokaryotic and eukaryotic
promoters. Most rely on chemical rather than physical
induction, and the strategy employed is based either on
transcriptional repression/activation or post-translational
sequestration/release [15]. Some of these systems have
been applied successfully to plant suspension cultures
[16]. We chose a tetracycline-inducible/derepressible sys-
tem based on a modified Cauliflower mosaic virus 35 S
promoter (Triple Op), in which three operator sequences
(tetO) from the Escherichia coli tetracycline operon sur-
round the TATA box [17]. The tetO sequences are recog-
nized by the tetracycline repressor (TetR), but its specific
binding activity is abolished in the presence of tetracycline
or an analog such as doxycycline. In transgenic plants that
express TetR constitutively, the Triple Op promoter can
therefore be derepressed by supplying tetracycline or
doxycycline [15,18]. This system has already been shown
to regulate transgene expression precisely in BY-2 cells, in-
cluding genes encoding β-glucuronidase, green fluorescent
protein and auxin binding protein 1 [17,19].
We have developed an improved tetracycline-inducible
system that is easy to handle, produces high yields of re-
combinant protein and that includes a constitutively-
expressed visible marker allowing the best-performing
clones to be selected rapidly. Stable transformation of
BY-2 cells with this vector resulted in the production of
3.5-fold higher levels of vIL-10 compared to constitutive
expression in the same host.
Results
Constitutive expression of murine and viral IL-10 in BY-2 cells
BY-2 suspension cell lines constitutively expressing viral
interleukin 10 (vIL-10) were produced by transformingwild-type cells with construct pTRAkt_ER-vIL-10, which
encodes an ER-targeted version of the protein under the
transcriptional control of the double enhanced CaMV
35 S promoter [14]. Although transgenic tobacco plants
expressing this construct were stunted, those expressing
an ER-targeted version of murine IL-10 did not show
an obvious morphological phenotype [14]. We there-
fore produced BY-2 lines constitutively expressing mur-
ine IL-10 as a control. These lines were generated by
transforming wild-type cells with construct pTRAkt_ER-
mIL-10, which is directly analogous to pTRAkt_ER-vIL-
10 and contains the same regulatory elements.
We screened 60 independent transgenic callus clones
for each construct by immunodotblot analysis to identify
the seven best-performing lines. These were tested by
ELISA to determine the precise levels of IL-10, and
the best performing clone for each construct was used
to establish liquid suspension cell cultures. We used the
same ELISA to determine the levels of IL-10 in cell pel-
lets from each culture prepared 3, 5 and 7 days after
subculture into fresh medium (days post-subculture,
dps). The highest yields were observed 5 dps in both
lines: 9.3 ± 1.4 μg/g fresh weight (FW) for mIL-10
(range = 2.4-9.3 μg/gFW of callus; average = 5.0; s.
d. = 2.8) and 1.4 ± 0.4 μg/g FW for vIL-10 (range = 0.4-
1.4 μg/g FW of callus; average 0.8, s.d. = 0.3). Less than
0.2% of each protein was detected in the culture super-
natant, as expected for a protein targeted for retention in
the ER. The recombinant proteins were of the correct size
and mIL-10 was glycosylated as expected (Additional file
2: Figure S2). There was no significant difference in the
growth properties of the cell suspension cultures based
on pellet weight, but it was clear that vIL-10 was pro-
duced at much lower levels than mIL-10. We proposed
that vIL-10 was toxic to plant cells, based on its effect on
transgenic plants, and that this toxicity had prevented the
recovery of high-yielding transgenic BY-2 lines. We there-
fore investigated the temporal restriction of vIL-10 pro-
duction using a tetracycline-inducible promoter.
Generation of a BY-2-TetR line
The strict regulation of transgene expression using a
tetracycline inducible promoter requires the generation
of a stable cell line expressing high levels of TetR. We
therefore transformed wild-type BY-2 cells with pBin-
TetR [17], containing the tetR gene under the control of
the CaMV 35 S promoter. Transformants were selected
on medium supplemented with kanamycin and 19 inde-
pendent callus clones were screened for tetR mRNA by
northern blot analysis (Figure 1). Clones #8, #10 and #16
were used to establish liquid suspension cultures, all
three of which grew well. We chose clone #10 for super-
transformation with our inducible vIL-10 constructs and
this cell line was named BY-2-TetR.
Figure 1 Northern blot analysis of independent BY-2 callus
clones transformed with pBin-TetR. Approximately 10 μg of total
RNA was loaded (except for #6 and #25 due to limited amounts of
biomass) and hybridized with a 32P-labeled TetR probe. Numbers
indicate the different clones. Top panels: images of the hybridized
blot as visualized on a phosphorimager. Bottom panels: agarose
gels stained with ethidium bromide to show intact 28 S and 18 S
rRNA bands.
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inducible transgene expression
We initially introduced the sequence for the ER-targeted
version of vIL-10 into pBinHygTX [17] to create pBin-
HygTX_vIL-10 (Figure 2). This was used to super-
transform the BY-2-TetR cell line but even by this stage
we were aware that the chosen vector system was sub-
optimal, in that the large size of pBinHygTX (12 kb,including 8.5 kb of backbone sequence) made subclon-
ing procedures unnecessarily complicated. The prelimin-
ary induction of transgene expression in transformed
callus clones was also more complex than anticipated
because the induction of BY-2 cells with anhydrotetracy-
cline (Ahtc) on solid medium as described [17] was not
uniform, giving rise to heterogeneous vIL-10 yields as
determined by immunodotblot or ELISA at each repeti-
tion (data not shown). We also tried an alternative strat-
egy of inducing vIL-10 expression while the callus was
in liquid medium directly after resuspension, but the
addition of Ahtc resulted in extensive cell death, prob-
ably due the higher toxicity of the chemical on the
already stressed cells.
We therefore decided to construct a vector carrying a
tandem expression cassette comprising the tetracycline-
inducible vIL-10 gene and the Discosoma spp. red fluor-
escent protein (DsRed) gene under the control of the
constitutive CaMV 35 S promoter. The visible marker
gene was included to facilitate the early selection of the
best-performing clones based on fluorescence intensity,
which correlates with the amount of protein [20]. We
switched to the pTRA vector series (derivatives of pPAM
[21]) because they have a smaller backbone than pBin
vectors (<3 kb) and are therefore more suitable for tan-
dem expression cassettes. Expression cassettes in the
pTRA vector used are also flanked by scaffold attach-
ment regions (SARs) from the tobacco RB7 gene [22],
and include the Tobacco etch virus 5′-UTR which pro-
motes protein synthesis [23]. To maximize the expres-
sion of vIL-10 we generated a tetracycline-inducible
CaMV 35 S promoter including an enhancer sequence.
The final vector was named pTRAh_DsRed-eTXvIL-10
(Figure 2).
Vector/promoter comparison
We tested the potential of the enhanced tetracycline-
inducible CaMV 35 S promoter in pTRAh_DsRed-eTX-
vIL-10 by transient expression in tobacco plants, using a
control vector lacking the tetO sequences. Wild-type
tobacco plants (Nicotiana tabacum cv. Petite Havana
SR1) were individually syringe-infiltrated with Agrobac-
terium tumefaciens strains carrying one of the four dif-
ferent vectors available for vIL-10 expression (Figure 3).
Wild-type tobacco plants do not produce TetR, so tran-
scription from all the promoters (including the inducible
ones) was constitutive, allowing the direct comparison
of their efficiency. Agroinfiltration was carried out in
such a way as to include all possible variations in vIL-10
expression due to the state of the plant/leaf material
(two plants, three leaves per plant, and randomized leaf
areas including the tip, center and base). We prepared
leaf discs from the infiltrated areas of all three leaves
from both plants at each time point, and pooled the
Figure 2 Schematic overview of the T-DNA cassettes used for constitutive and inducible expression of vIL-10. LB and RB, left and right
border of the T-DNA; P35STX, Inducible Cauliflower mosaic virus 35 S promoter; Pe35S, CaMV 35 S promoter with enhancer (double arrowheads);
TX, three tetO sites (TetR binding sites, gray circle) surrounding the TATA box; OCS, octopine synthase gene terminator; pAg7, agropine synthase
gene terminator; Pnos and pAnos, nopaline synthase gene promoter and terminator; hpt, hygromycin phosphotransferase gene; nptII, neomycin
phosphotransferase gene; SAR, scaffold attachment region; pA, terminator of the CaMV 35 S gene; TL, 5′ UTR of the Tobacco etch virus; vIL-10,
viral IL-10 coding sequence with native signal peptide sequence at the 5′ end and sequences for a His6 tag and ER retention signal (SEKDEL)
at the 3′ end; TP, plastid transit peptide from the barley granule-bound starch synthase gene; DsRed, Discosoma spp red fluorescent protein.
The full name of the vector is shown to the side of each diagram and the vector backbone and promoter are indicated in parentheses.
Not drawn to scale.
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by ELISA (Figure 3). We assumed that the onset of
necrosis in the tissue infiltrated with pTRA_e35STX at
6 dpi represented high levels of recombinant protein
expression (like the stunted phenotype of transgenic
plants) even though detected vIL-10 in the necrotic tissue
was lower due to high levels of proteolytic activity and
inefficient protein extraction. We were thus able to rank
the promoters/vector combinations in descending order ofFigure 3 Time course analysis of vIL-10 accumulation in wild-type tob
expression constructs. ELISAs were used to determine vIL-10 levels in lea
as μg/g FW. Vector abbreviations correspond to those in Figure 2. The inse
necrotic at 6 dpi (pTRA_e35STX).activity as follows: pTRA_e35STX≥pTRA_35STX >>
pBin_35STX (Figure 3). The comparison of pTRA_35STX
and pTRA_e35STX indicated that the additional enhan-
cer sequence in pTRA_e35STX has a significant impact
on recombinant protein accumulation, resulting in the
appearance of necrotic lesions in the infiltrated area by
6 days post-infiltration. The pBin_35TX vector was an
order of magnitude less efficient than any of the vectors
based on pTRA.acco leaves following infiltration with bacteria carrying different
f protein extracts at 3, 4, 5 and 6 days post infiltration (dpi), expressed
rt show the phenotype of the infiltrated leaf tissue, which was mostly
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The BY-2-TetR line was super-transformed with
pTRAhDsRed-eTXvIL-10 and over a hundred independ-
ent callus clones were derived by double selection on
medium containing kanamycin and hygromycin. We
then selected the callus clones displaying macroscopic-
ally uniform DsRed fluorescence because this is usually a
good indicator of the expression levels of a linked trans-
gene (Figure 4A). Nine callus clones representing low
(#26, #28, #35) medium (#2, #5, #48) and high (#22, #36,
#44) levels of DsRed fluorescence were identified by eye
and transferred directly into liquid medium to establish
suspension cell cultures (Fig. 4B).
As for the best two lines induction 3 days after subcul-
ture resulted in overall lower vIL-10 yields compared to
induction directly at the time of subculture (e.g. 4.1 vs.
5.3 μg/g FW for line #44, Additional file 3: Figure S3),
we then tested for correspondence between DsRed fluor-
escence intensity and vIL-10 yields by inducing all cell
lines with 10 μM Ahtc at the next subculture interval.
The amount of vIL-10 in cell pellet extracts was deter-
mined by ELISA at 3, 5 and 7 days post-induction (dpi)
(Figure 5A). The yield of the recombinant protein
increased over time, with the highest levels of vIL-10
detected 7 dpi for all lines. A similar trend in protein
accumulation was observed for the constitutive expressionFigure 4 Selection of transgenic BY-2 lines based on DsRed fluoresce
lamp with glass fiber optics (Leica KL1500), an additional filter for green ex
independent transgenic BY-2 callus clones that show macroscopically diffe
cultures of BY-2 cells, wild-type cells on the left and transgenic cells expresof the same transgenes in newly-established suspension
cultures whose growth in liquid medium had not been
completely stabilized (data not shown). In addition to
the preliminary visual evaluation of DsRed levels in the
transgenic callus clones, we quantified the levels of DsRed
protein in extracts from the callus clones and the derived
cell suspension cultures (Figure 5B). There was excel-
lent correspondence between the visual evaluations and
accurately-determined protein levels in all cases. The
amount of DsRed in the callus clones was generally
slightly higher than in the corresponding suspension cells.
As expected, there was also a good correlation between
the amount of vIL-10 measured at 7 dpi and the level of
DsRed fluorescence in the same clones (Figure 5C). Line
#44 produced the highest yields of vIL-10 and was evalu-
ated by ELISA in three independent induction experi-
ments, sampling the culture daily from 3 to 7 dpi
(Figure 6). The results were reproducible, with vIL-10
yields of up to 5.3 μg/g FW by 4 dpi, which is more than
3.5 times higher than the best-performing constitutive
lines (1.4 ± 0.4 μg/g FW, Figure 6). Negligible amounts of
vIL-10 were found in the non-induced control cultures of
even the best-performing transgenic lines (undetectable
for line #36, 0.013 μg/g FW for line #44), indicating that
the BY-2-TetR cassette is tightly regulated and does not
show significant leakiness.nce. DsRed fluorescence (lower panels) was visualized using an LCD
citation (BP545/30) and a colored foil (#182, light red). (A) Four
rent fluorescence intensity and homogeneity. (B) Liquid suspension
sing DsRed on the right.
Figure 5 Comparison of DsRed and vIL-10 accumulation levels. (A) Cell suspension cultures from different lines were induced with 10 μM
Ahtc and 2-ml aliquots were analyzed daily from 3 to 7 dpi. The accumulation of vIL-10 in cell pellet extracts was determined by ELISA. (B) DsRed
accumulation was determined in callus and cell suspension culture extracts from each transgenic line arrayed in 96-well plates using a
fluorometer. The data reported are means ± SD from three independent experiments. (C) Linear regression between the yields of IL-10 (in
suspension cultures at 7 dpi) and DsRed (in callus) for nine clones. The correlation coefficient R2 is indicated inside the plot.
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The growth of the transgenic lines with the highest vIL-10
levels post-induction (lines #44 and #36) was monitored
under both the induced and non-induced states alongsidewild-type BY-2 cells, and the biomass was determined at
different intervals. As shown in Figure 7A,B, the growth
curves of both transgenic lines are similar in the pres-
ence and absence of Ahtc, indicating that neither the
Figure 6 Comparison of constitutive and inducible vIL-10
accumulation in BY-2 cell suspension cultures. Samples
were taken from cultures expressing vIL-10 constitutively (cells
transformed with pTRAkt_ER-vIL-10, black bars) at 3, 5 and 7 days
post subculture. Samples were taken from cultures expressing vIL-10
under induction (cells transformed with pTRAh_DsRed-eTXvIL-10,
grey bars) daily from 3 to 7 days post induction. The accumulation
of vIL-10 was determined in cell pellet extracts by ELISA. The data
reported are expressed as μg/g FW and represent the means ± SD
from three independent experiments.
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impact on cell growth during the investigated timeframe.
In contrast, the addition of Ahtc to the wild-type cells
reduced their growth significantly (Figure 7C). In the
transgenic lines, binding of the TetR protein to free Ahtc
probably prevents its toxic effect [24].
Discussion
Plant cell suspension cultures are emerging as a useful
platform for the manufacture of recombinant proteins
[25-28]. Production lines can be generated and scaled up
more quickly and with lower costs than systems based
on whole plants [29]. Plant cells are also advantageous
because recombinant proteins can be secreted into
and recovered from the culture medium. They allow
pharmaceuticals to be produced under current good
manufacturing practice in bioreactor-based processes.
Efficient and reliable inducible expression systems can
improve the versatility of plant cell cultures still fur-
ther by restricting protein expression to the most pro-
ductive growth phase and preventing exposure to
proteases which reduce both the quantity and the quality
of the product. Inducible promoters allow transgene
expression to be delayed until the culture has reached a
suitable biomass in the late exponential growth phase,
allowing production to be uncoupled from plant cell
growth [15].
Tetracycline-specific derepressible expression [30] is a
widely-characterized inducible system in plants that has
been successfully applied in tobacco BY-2 cells [17]. We
have developed an improved version using a tandem
construct incorporating a constitutive visual markergene that allows the rapid and straightforward selection
of the best-performing transgenic lines.
The first improvement was achieved by transferring
the expression cassette from a pBin vector to pTRA,
resulting in a substantial increase in recombinant pro-
tein yields by transient expression in tobacco. This prob-
ably reflects the influence of the Tobacco etch virus 5′-
UTR, which acts as a translational enhancer in plants
[23]. The pTRA vector also contains flanking scaffold at-
tachment regions (SARs), which are known to enhance
transcriptional activity and mitigate silencing effects by
defining a stable chromatin domain [22,31,32]. Although
stable transgenic lines were not generated with the pBin
vector, transient expression experiments usually pro-
vide a reliable indication of the outcome of stable trans-
formation [33-35], thus it is reasonable to anticipate
superior performance from the pTRA vector in stable
transgenic lines.
The second improvement was achieved by adding a
CaMV 35 S enhancer upstream of the tetracycline-
inducible Triple-Op promoter. The presence of the
enhancer sequence significantly increases the activity of
the native CaMV 35 S promoter [36]. We anticipated
similar benefits in the context of the Triple-Op pro-
moter because it differs from the native promoter only
in the presence of three tetO sequences surrounding
the TATA box, and their presence should not hamper
the synergistic interaction between the enhancer and
minimal promoter.
The third and most innovative improvement was the
tandem configuration of the inducible transgene and a
constitutive visual marker gene, which greatly simplified
the procedure for selecting the best-performing clones.
Transgene expression is strongly influenced by the chro-
matin surrounding the integration site so tightly linked
transgenes are generally subjected to the same global
regulatory factors. This means that a gene encoding a
fluorescent protein can be used as a surrogate marker
to determine the activity of a linked transgene whose
product can only be detected using as less convenient
off-line assay. In this case, we found that the intensity of
DsRed fluorescence was proportional to the amount of
DsRed protein, which in turn was indicative of the
amount of vIL-10. Although we observed a good correl-
ation between the marker and the primary gene product,
many factors could uncouple the yields of adjacent
transgenes such as multiple or partial T-DNA insertions
and transgene rearrangements. The DsRed gene was
placed adjacent to the right-hand T-DNA border in our
vector, and since the right-hand border is transferred
first this configuration is more likely to produce false
positives (strong fluorescence without corresponding
vIL-10 accumulation) than false negatives (strong vIL-10
expression without fluorescence). Even so, the advantage
Figure 7 (See legend on next page.)
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(See figure on previous page.)
Figure 7 Growth curves of BY-2 suspension cells with (+) and without 10 μM Ahtc treatment at subculture. We withdrew 5-ml samples
from 50-ml cultures of transgenic lines #44 (A) and #36 (B) or wild-type (C) cells at 3, 5 and 7 dpi, vacuum filtered the cells through filter paper
discs (MN615) and recorded the dry biomass weight after drying at 37 °C for 48 h. The data reported are means ± SD of three independent
experiments.
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that second-stage screening following induction of the
linked transgene is limited to a handful of promising
clones, rather than tens or hundreds [37]. Should it be
so desired, it is also still possible within our platform to
analyze antibiotic resistant callus clones that lack DsRed
fluorescence to identify potential false negative lines that
produce high levels of vIL-10. We used a precise fluoro-
metric assay to determine the levels of DsRed fluores-
cence in order to carry out a quantitative comparison
between DsRed and vIL-10 expression and demonstrate
the predictive accuracy of our platform. However, for
routine deployment such a precise assay is unnecessary.
The human eye cannot distinguish small variations in
fluorescence but is sufficient to identify the brightest
callus clones on a plate using a green fluorescent light
and a red filter, allowing the rapid visual selection of
promising clones without sophisticated apparatus.
Finally, the constitutively expressed visual marker can
also be used as an internal control to monitor the genetic
stability of selected transgenic lines during prolonged culti-
vation with multiple subcultures. Any loss of fluorescence
would be a strong indicator of transgene disruption/loss by
recombination or the onset of epigenetic gene silencing.
The combination of improvements discussed above
resulted in a highly reproducible increase in the accumu-
lation of vIL-10, 3.5 times higher than those obtained by
constitutive expression in the same cell line. The indu-
cible expression cassette was highly efficient, benefiting
from a low basal expression level and a high induction
ratio. We did not replenish Ahtc in the culture medium
so vIL-10 accumulation peaked at 4 dpi in well-
established suspension cultures and decreased thereafter
(Figure 6). Further increases in yield might be achieved
by optimizing the concentration and dosing method of
the inducer and the timing of induction.
As well as its value in the field of molecular farming,
the inducible expression cassette could also be useful for
basic research by allowing the precisely-regulated over-
expression or silencing of endogenous genes [15]. The
accurate measurement of reporter protein fluorescence
would allow the selection of cell lines with different
levels of transgene expression, allowing quantitative
effects to be monitored rather than the binary on/off
choice that conventional assays allow. In that regard,
DsRed has been used as reporter gene in BY-2 cells [38],
whole plants [20,39], fungi [40] and animals [41] without
any reports of adverse effects on the host.Conclusions
We have developed a more efficient and more conveni-
ent version of the widely used tetracycline-inducible
expression system, and have used it to increase the accu-
mulation of the toxic cytokine vIL-10 in BY-2 cell sus-
pension cultures. The new platform increases both the
quality and the quantity of the final product, and allows
the high-level production of recombinant proteins that
would affect the growth and vitality of cells when
expressed constitutively. Although we demonstrated the
platform using BY-2 cells to produce vIL-10, the compo-
nents can be transferred easily to any other host cell,
allowing the platform to be used both for molecular
farming and basic research.
Methods
Constructs
Vectors pTRAkt_ER-vIL-10 and pTRAkt_ER-mIL-10
have already been described [14]. Vectors pBinHygTx,
pBinTetR and pUC-TetR were kindly provided by Prof.
Dr. Christiane Gatz (Georg-August-Universität Göttingen,
D). Vector pBinHygTx_vIL-10 was generated by amplify-
ing the vIL-10 coding sequence from vector pTRAkt_ER-
vIL-10 to introduce KpnI and XbaI restriction sites
at the 5′ and 3′ termini, using primers KpnI_vIL-10_for
(5′-CGG GGT ACC ATG GAG CGA AGG TTA GTG
GTC-3′) and vIL-10-KDEL_rev (5′-GCT CTA GAC
GGT TTA GAG CTC ATC TTT CTC AGA CCT GGC
TTT AAT TGT CAT GTA TGC-3′). The PCR product
was then transferred as a KpnI-XbaI fragment into pBin-
HygTx, linearized with the same enzymes.
To generate the other vectors, a 562-bp fragment
comprising the CaMV 35 S promoter with three tetO
sites was amplified from vector pBinHygTx using pri-
mers 35 S-TOP5 (5′-CAA TGG CGC GCC AAA GAT
TCA AAT AGA G-3′) and 35 S-TOP3 (5′-TCC CCG
AAT TCC GTT AAC TC-3′). The product was digested
with AscI and EcoRI (546 bp) or AccI and EcoRI
(414 bp). The AscI-EcoRI fragment was introduced,
together with a 693-bp EcoRI-XbaI fragment from
pTRAkt_ER-vIL-10 containing the Tobacco etch virus
5′-UTR and the coding sequence of vIL-10, into pTRAh
(pTRA vector containing a hygromycin phosphotransferase
marker) digested with AscI and XbaI to create pTRAhTX_
vIL-10. The AccI-EcoRI fragment was introduced, together
with the 693-bp EcoRI-XbaI vIL-10 fragment into pTRAh
digested with AccI and XbaI to generate pTRAheTX_vIL-
10. The pTRAh_DsRed-eTXvIL-10 vector was generated
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from pTRAk-2F5ER-Ds [29], containing a constitutively-
expressed and plastid-targeted DsRed gene, into pTRA-
heTX_vIL-10.
Cell culture maintenance, transformation and biomass
determination
Tobacco (Nicotiana tabacum cv. Bright Yellow 2; BY-2)
suspension cells were cultivated in liquid medium
(3% (w/v) sucrose, 4.4 g/L Murashige and Skoog (MS)
salts with minimum organics, 0.4 mg/l thiamine, 0.2 mg/L
2,4-dichlorophenoxyacetic acid, 200 mg/L KH2PO4, pH
5.8) at 26 °C in the dark, shaking at 180 rpm. Suspension
cells were subcultured weekly using a 5% (v/v) inoculum.
Callus cultures were maintained on solid medium (MS
medium plus 0.8% (w/v) agar) in the dark and transferred
as necessary.
BY-2 cells were transformed by co-cultivation with
Agrobacterium tumefaciens (strain GV3101:pMP90RK
for the pTRA based vectors, and GV2260 for pBin
based vectors) by adding 150 μl of bacterial suspension
(OD600 ~1) to 3 ml of a 3-day-old suspension cell cul-
ture supplemented with 200 μM acetosyringone. After
3 days of co-incubation at 26 °C, cells were plated onto
solid medium containing 200 mg/L cefotaxime and
either 100 mg/L kanamycin (for pBinTetR, pTRAkt_ER-
mIL-10 and pTRAkt_ER-vIL-10) or 100 mg/L kanamycin
and 50 mg/L hygromycin (for the super-transformation
of BY-2-TetR with pBinHygTX_vIL-10, pTRAhDsRed-
eTXvIL-10 and pTRAh-TXvIL-10). After incubation for
3–4 weeks at 26 °C, antibiotic-resistant callus clones
were screened for DsRed fluorescence and transferred to
fresh plates. The expanded clones were used to establish
cell suspension cultures. The cultures were induced by
adding 10 μM Ahtc (Sigma-Aldrich, St. Louis, Mo, USA)
to the liquid medium during subculture.
Biomass dry weight was determined by vacuum filter-
ing 5 ml of each culture through filter paper (MN615,
Macherey & Nagel, Düren, Germany), and drying the
cells at 37 °C for 48 h.
Northern blot analysis
Northern blot analysis was carried out as previously
described [42]. Briefly, total RNA was prepared from
transgenic callus tissue using the NucleoSpin RNA plant
kit (Macherey & Nagel). We loaded 10 μg of total
RNA onto a denaturing agarose gel and blotted the sepa-
rated nucleic acids onto a positively charged nylon mem-
brane, which was probed with a 32P-labeled 1.4-kb
EcoRI/HindIII fragment released from pUC-TetR.
Isolation of total soluble proteins and IL-10 quantification
Approximately 200 mg of callus tissue or cell pellet bio-
mass prepared from the liquid culture by centrifugationfor 10 min at 16,000 g, 4 °C were weighed in a 2-ml
plastic tube, and sonicated on ice for 1 min (9 x 10%
cycle, 35% power) with two volumes of BY-2 extraction
buffer (PBS pH 7.4, 0.05% (v/v) Tween-20, 5 mM EDTA,
pH 8.0, (v/v) freshly added DMSO). The clear super-
natant was separated from cell debris by centrifugation
at 16,000 x g for 30 min at 4 °C, and the total soluble
protein content was determined using the RotiWQuant
reagent (Roth, Karlsruhe, Germany). Murine and viral IL-
10 levels were quantified by sandwich ELISA [14]. The
detection limit of IL-10 in ELISA is ~10 pg/ml for the
viral and ~50 pg/ml for the murine IL-10, respectively.
Visualization and quantitation of DsRed fluorescence
DsRed fluorescence was visualized in transiently infil-
trated tobacco leaves, stably transformed BY-2 callus
clones and cell suspension cultures using an LCD lamp
with glass fiber optics (KL1500, Leica, Wetzlar, Germany),
an additional filter for green excitation (Leica BP545/30)
and a colored foil (# 182 light red, Lee Filters, Andover,
UK). DsRed fluorescence in cell extracts was quantified in
96-well plates using a Synergy HT microtiterplate reader
(Bio-TEK, Bad Friedrichshall, Germany) against a calibra-
tion curve prepared from 50 to 0.04 μg/ml solutions of
home-made affinity-purified DsRed stock.
Additional files
Additional file 1: Figure S1. Phenotype of transgenic tobacco
(Nicotiana tabacum cv. Petite Havana SR1) plants stably
transformed with the pTRAkt_ER-vIL-10 construct (constitutive
vIL-10 expression). Analysis of vIL-10 accumulation levels in transgenic
tobacco plants revealed a striking correspondence between the stunted
phenotype and the amounts of recombinant protein detected in the leaf
tissue. In this figure, three T1 plants of the same age and grown under
the same conditions, representative of the range of phenotypic
alterations observed, are shown, and the corresponding accumulation
levels of vIL-10 measured by ELISA in the leaf extract are reported below
each plant (A). No differences could be detected regarding the
appearance or the growth rate of the transgenic plant accumulating
vIL-10 to the lowest level and the wild type (not shown). (B)
Enlargement of the dwarf plant in (A), which accumulates vIL-10 at the
highest levels and displays the strongest phenotype observed. Note that,
besides the stunted appearance, with shorter internodes and smaller
leaves, this plant is still in a vegetative state, while the least-expressing
normal-looking plant of the same age is already flowering. (C) Side view
of the same transgenic plants shown in (A), underlining the enormous
difference in growth and development between the three expressers.
Additional file 2: Figure S2. Biochemical characterization of
BY-2-produced viral and murine IL-10. (A). Immunoblot analysis of
recombinant vIL-10 and mIL-10 purified from transgenic BY-2 cells
confirmed the correct molecular weight of 19 and 21 kDa, respectively.
(B). The purified proteins were digested with trypsin and the peptides
subjected to LC-MS analysis. As expected, vIL-10 was not glycosylated
(not shown). The murine IL-10 was confirmed to be glycosylated and the
N-glycans found were only of the oligo-mannose-type, as expected for a
protein retained in the ER. The spectrum of the glycosylated peptide is
shown. See http://www.proglycan.com for an explanation of N-glycan
abbreviations. For the methods refer to Bortesi et al. 2009.
Additional file 3: Figure S3. Time course analysis of vIL-10
accumulation in transgenic cultures induced 3 days after
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http://www.biomedcentral.com/1472-6750/12/40subculture. Cell suspension cultures the two most promising lines were
induced with 10 μM Ahtc 3 days after subculture and 2-ml aliquots were
analyzed daily from 1 to 4 dpi. The accumulation of vIL-10 in cell pellet
extracts was determined by ELISA. The data reported are expressed as
μg/g FW and represent the means ± SD from three independent
experiments.
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